Literature DB >> 21073138

Factors of occurrence of ocular toxoplasmosis. A review.

H Talabani1, T Mergey, H Yera, E Delair, A P Brézin, G Langsley, J Dupouy-Camet.   

Abstract

Acquired and congenital toxoplasmosis are frequently complicated by ocular toxoplasmosis. The diagnosis relies on clinical aspects, response to specific treatment and results of biological assays. The incidence and the prevalence of this complication are difficult to establish precisely and depend on the prevalence of the parasite infection in the general population, and are affected by factors such as type of exposure to the parasite, genetic backgrounds of the parasite and the host, and type of immune response elicited by the parasite.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21073138     DOI: 10.1051/parasite/2010173177

Source DB:  PubMed          Journal:  Parasite        ISSN: 1252-607X            Impact factor:   3.000


  10 in total

1.  Toxoplasmosis: new challenges for an old disease.

Authors:  B Bodaghi; V Touitou; C Fardeau; L Paris; P LeHoang
Journal:  Eye (Lond)       Date:  2012-01-06       Impact factor: 3.775

2.  Clinical pattern of ocular toxoplasmosis treated in a referral centre in Serbia.

Authors:  D Kovačević-Pavićević; A Radosavljević; A Ilić; I Kovačević; O Djurković-Djaković
Journal:  Eye (Lond)       Date:  2012-02-24       Impact factor: 3.775

3.  Phosphodiesterase inhibitors as a new generation of antiprotozoan drugs: exploiting the benefit of enzymes that are highly conserved between host and parasite.

Authors:  Thomas Seebeck; Geert Jan Sterk; Hengming Ke
Journal:  Future Med Chem       Date:  2011-08       Impact factor: 3.808

4.  Cerebral and ocular toxoplasmosis related with IFN-γ, TNF-α, and IL-10 levels.

Authors:  Cristina S Meira; Vera L Pereira-Chioccola; José E Vidal; Cinara C Brandão de Mattos; Gabriela Motoie; Thais A Costa-Silva; Ricardo Gava; Fábio B Frederico; Luiz C de Mattos
Journal:  Front Microbiol       Date:  2014-10-13       Impact factor: 5.640

5.  Immune Mediator Profile in Aqueous Humor Differs in Patients with Primary Acquired Ocular Toxoplasmosis and Recurrent Acute Ocular Toxoplasmosis.

Authors:  Claudia Thieme; Stephan Schlickeiser; Sylvia Metzner; Claudia Dames; Uwe Pleyer
Journal:  Mediators Inflamm       Date:  2019-02-17       Impact factor: 4.711

6.  Screening for common eye diseases in the elderly with Optos ultra-wide-field scanning laser ophthalmoscopy: a pilot study with focus on ocular toxoplasmosis.

Authors:  Pablo Eduardo Logroño Wiese; Frank Seeber; Anne-Sophie Endres; Claudia Brockmann; Uwe Pleyer
Journal:  Int Ophthalmol       Date:  2021-03-16       Impact factor: 2.031

7.  Macular Infarction following Intravitreal Clindamycin Injection : A Case Report.

Authors:  Alireza Hedayatfar; Amin Zand; Hooshang Faghihi; Arzhang Gordiz; Fatemeh Abdi
Journal:  J Curr Ophthalmol       Date:  2021-10-22

8.  Intravitreal Clindamycin and Dexamethasone Combined with Systemic Oral Antitoxoplasma Therapy versus Intravitreal Therapy Alone in the Management of Toxoplasma Retinochoroiditis: A Retrospective Study.

Authors:  Ashraf Bor'i; Ashraf Mahrous; Mahmoud A Al-Aswad; Haitham Y Al-Nashar; Waled M Nada; Mostafa Wagih; Ahmed M B Awad; Wael M El-Haig
Journal:  J Ophthalmol       Date:  2018-02-12       Impact factor: 1.909

9.  Toxoplasmosis in Transplant Recipients, Europe, 2010-2014.

Authors:  Florence Robert-Gangneux; Valeria Meroni; Damien Dupont; Françoise Botterel; José M Aguado Garcia; Marie-Pierre Brenier-Pinchart; Isabelle Accoceberry; Hamdi Akan; Isabella Abbate; Katia Boggian; Fabrizio Bruschi; Jordi Carratalà; Miruna David; Lubos Drgona; Olgica Djurković-Djaković; Maria Carmen Farinas; Francesca Genco; Effrossyni Gkrania-Klotsas; Andreas H Groll; Edward Guy; Cédric Hirzel; Nina Khanna; Özgür Kurt; Lia Monica Junie; Tiziana Lazzarotto; Oscar Len; Nicolas J Mueller; Patricia Munoz; Zoi Dorothea Pana; Emmanuel Roilides; Tijana Stajner; Christian van Delden; Isabelle Villena; Hervé Pelloux; Oriol Manuel
Journal:  Emerg Infect Dis       Date:  2018-08       Impact factor: 6.883

10.  Serum levels of neurotrophic factors in active toxoplasmic retinochoroiditis.

Authors:  Cynthia Azeredo Cordeiro; Erica Leandro Marciano Vieira; Natália Pessoa Rocha; Vinicius Monteiro Castro; Juliana Lambert Oréfice; Tatiana Barichello; Rogerio Alves Costa; Fernando Oréfice; Lucy Young; Antonio Lucio Teixeira
Journal:  Braz J Infect Dis       Date:  2016-12-05       Impact factor: 3.257

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.